Eqis Capital Management Inc. acquired a new stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 3,270 shares of the company’s stock, valued at approximately $210,000.
A number of other hedge funds also recently bought and sold shares of USNA. Victory Capital Management Inc. increased its stake in USANA Health Sciences by 124.7% in the first quarter. Victory Capital Management Inc. now owns 2,117 shares of the company’s stock valued at $122,000 after buying an additional 1,175 shares in the last quarter. Creative Planning increased its stake in USANA Health Sciences by 528.0% in the second quarter. Creative Planning now owns 2,512 shares of the company’s stock valued at $161,000 after buying an additional 2,112 shares in the last quarter. Nine Chapters Capital Management LLC bought a new stake in USANA Health Sciences during the first quarter valued at approximately $207,000. KCG Holdings Inc. bought a new stake in USANA Health Sciences during the first quarter valued at approximately $248,000. Finally, Highbridge Capital Management LLC bought a new stake in USANA Health Sciences during the first quarter valued at approximately $254,000. 43.90% of the stock is owned by hedge funds and other institutional investors.
USANA Health Sciences, Inc. (NYSE USNA) opened at 58.80 on Friday. The firm has a market cap of $1.47 billion, a PE ratio of 15.27 and a beta of 1.10. The firm’s 50-day moving average price is $61.41 and its 200 day moving average price is $60.57. USANA Health Sciences, Inc. has a 52-week low of $52.55 and a 52-week high of $150.00.
USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.06 by $0.08. The business had revenue of $257.10 million for the quarter, compared to the consensus estimate of $273.61 million. USANA Health Sciences had a net margin of 9.47% and a return on equity of 30.12%. The business’s quarterly revenue was down .5% on a year-over-year basis. During the same period last year, the firm posted $2.07 EPS. On average, equities analysts anticipate that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current year.
USANA Health Sciences declared that its board has approved a share buyback plan on Tuesday, July 25th that authorizes the company to buyback $64.60 million in outstanding shares. This buyback authorization authorizes the company to buy up to 46% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.
TRADEMARK VIOLATION WARNING: “Eqis Capital Management Inc. Takes Position in USANA Health Sciences, Inc. (USNA)” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/08/12/3270-shares-in-usana-health-sciences-inc-usna-acquired-by-eqis-capital-management-inc-updated.html.
Several research firms have commented on USNA. BidaskClub downgraded USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research note on Monday, July 31st. Pivotal Research reduced their price objective on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a research note on Wednesday, July 26th.
In related news, Director Myron W. Wentz sold 40,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 5th. The shares were sold at an average price of $64.15, for a total transaction of $2,566,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Paul A. Jones sold 9,851 shares of the firm’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $64.50, for a total transaction of $635,389.50. Following the transaction, the insider now owns 6,020 shares in the company, valued at approximately $388,290. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 171,334 shares of company stock worth $10,413,675. Corporate insiders own 53.20% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
What are top analysts saying about USANA Health Sciences Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for USANA Health Sciences Inc. and related companies.